India Drug-Approval Slowdown Prompts Some CROs To Consider Leaving
This article was originally published in PharmAsia News
Executive Summary
India's process for approving drugs is so slow some contract research organizations are thinking about moving their clinical trials elsewhere, according to companies and groups associated with the pharmaceutical industry.